期刊
PANCREATOLOGY
卷 14, 期 1, 页码 27-35出版社
ELSEVIER
DOI: 10.1016/j.pan.2013.10.009
关键词
Hereditary pancreatitis; Pancreatic surgery; Pancreatic adenocarcinoma; Pancreatic cancer; Diabetes mellitus
资金
- National Institute of Diabetes and Digestive and Kidney Diseases [R13DK083216, R13DK088452, R13DK09604]
- Abbott Laboratories
- Aptalis Pharma
- Boston Scientific
- Cook Medical
- Lilly
- Olympus through the University of Pittsburgh office of Continuing Medical Education
Description: Total pancreatectomy with islet autotransplantation (TPIAT) is a surgical procedure used to treat severe complications of chronic pancreatitis or very high risk of pancreatic cancer while reducing the risk of severe diabetes mellitus. However, clear guidance on indications, contraindications, evaluation, timing, and follow-up are lacking. Methods: A working group reviewed the medical, psychological, and surgical options and supporting literature related to TPIAT for a consensus meeting during PancreasFest. Results: Five major areas requiring clinical evaluation and management were addressed: These included: 1) indications for TPIAT; 2) contraindications for TPIAT; 3) optimal timing of the procedure; 4) need for a multi-disciplinary team and the roles of the members; 5) life-long management issues following TPIAP including diabetes monitoring and nutrition evaluation. Conclusions: TPIAT is an effective method of managing the disabling complications of chronic pancreatitis and risk of pancreatic cancer in very high risk patients. Careful evaluation and long-term management of candidate patients by qualified multidisciplinary teams is required. Multiple recommendations for further research were also identified. Copyright (C) 2013, IAP and EPC. Published by Elsevier India, a division of Reed Elsevier India Pvt. Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据